Search results for “Anti-Carcinogenic Agents” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 917 patents, we discovered top 295 key players by total patent application. Bristol Myers Squibb Co., Aventis Pharma, F. Hoffmann-La Roche Ltd. are dominant in this area. They take 14.83% of the total patent filing.
New York, United States
Patent: 73
Belgium
Patent: 32
Switzerland
Patent: 31
Jiangsu Sheng, China
Patent: 25
New York, United States
Patent: 24
Massachusetts, United States
Patent: 20
Basel-Stadt, Switzerland
Patent: 19
United Kingdom
Patent: 15
New Jersey, United States
Patent: 12
Pennsylvania, United States
Patent: 12
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 33 patents, we discovered top 14 start-ups by total patent application. Volterra, Inc., Institut National de la Santé et de la Recherche Médicale, GI Innovation, Inc. are active in this area.
STARTUP
California, United States
Patent: 7
STARTUP
South Korea
Patent: 5
STARTUP
Massachusetts, United States
Patent: 2
STARTUP
ZURICH, Switzerland
Patent: 2
STARTUP
New York, United States
Patent: 1
STARTUP
Bridge Financial Technology, Inc.
Illinois, United States
Patent: 1
STARTUP
Texas, United States
Patent: 1
STARTUP
Shanghai Shi, China
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 463 patents applied in the last 5 years. We discover 189 most active companies in this area. The fast-growing Bristol Myers Squibb Co., AstraZeneca Pharmaceutical Co., Ltd., Novartis AG take 14.90% of patent filing during this period.
New York, United States
Patent: 29
Jiangsu Sheng, China
Patent: 22
Basel-Stadt, Switzerland
Patent: 18
New York, United States
Patent: 13
California, United States
Patent: 10
New Jersey, United States
Patent: 10
South Korea
Patent: 8
STARTUP
California, United States
Patent: 7
New Jersey, United States
Patent: 7
Fukuoka-ken, Japan
Patent: 7
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 463 patents in last 5 years, we discover 137 new entrants. Beta Pharma, Inc., Biometrix Technology, Inc., Volterra, Inc. are the most active new entrants in this area.
New Jersey, United States
Patent: 10
South Korea
Patent: 8
STARTUP
California, United States
Patent: 7
Fukuoka-ken, Japan
Patent: 7
Braga, Portugal
Patent: 6
Shanghai Shi, China
Patent: 6
STARTUP
South Korea
Patent: 5
Jiangsu Sheng, China
Patent: 5
New Jersey, United States
Patent: 5
Massachusetts, United States
Patent: 4
Research Institutions
Order by:
Innovation Intensity
With the analysis among 239 patents, we discovered top 71 universities and scientific research institutions by total patent application. Korea Institute of Science & Technology, Kyushu University, Institute Of Cancer Research are dominant in this area. They take 18.83% of the total patent filing.
South Korea
Patent: 8
Fukuoka-ken, Japan
Patent: 7
United Kingdom
Patent: 7
Braga, Portugal
Patent: 6
Delhi, India
Patent: 4
Tokyo-to, Japan
Patent: 4
New South Wales, Australia
Patent: 4
South Korea
Patent: 4
Tokyo-to, Japan
Patent: 3
Georgia, United States
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: